@article{pediconi:hal-01305476,
TITLE = {Libertas: a phase II placebo-controlled study of NRL001 in patients with faecal incontinence showed an unexpected and sustained placebo response},
AUTHOR = {Pediconi, C. and Pilot, J. and Wexner, S. and Scholefield, J and Siproudhis, L. and Graf, W. and Emmanuel, A. and Walker, D. and Shing, R. Ng Kwet},
URL = {https://univ-rennes.hal.science/hal-01305476},
JOURNAL = {International Journal of Colorectal Disease},
PUBLISHER = {Springer Verlag},
VOLUME = {31},
NUMBER = {6},
PAGES = {1205--1216},
YEAR = {2016},
MONTH = Apr, DOI = {10.1007/s00384-016-2585-7},
KEYWORDS = {Alpha-1 receptor agonist ; NRL001 ; Faecal incontinence ; Episode frequency ; Quality of Life},
HAL_ID = {hal-01305476},
HAL_VERSION = {v1},
}